- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05669443
Effect of Optimized PEEP on Mechanical Ventilation During Robot Assisted Laparoscopic Prostatectomy
April 5, 2024 updated by: Chul Ho Chang, Gangnam Severance Hospital
Application of Individualized Positive End-expiratory Pressure Using Electrical Impedance Tomography (EIT) in Patients Undergoing Robot Assisted Laparoscopic Prostatectomy : a Randomized Controlled Study
Steep trendelenburg posture or pneumoperitoneum for surgery causes ventilation problems during surgery, so finding a way to overcome is a challenging task for anesthesiologists.
In this study, for patients undergoing robot assisted laparoscopic prostatectomy under general anesthesia, anesthesia is going to perform by applying conventional positive end-expiratory pressure (PEEP 5cmH2O) or individually determined positive end-expiratory pressure values for each patient using electrical impedance tomography.
We plan to compare intraoperative ventilation through arterial blood gas analysis to find out the way to improve intraoperative ventilation.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
42
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Chul-Ho Chang
- Phone Number: 82-2-2019-4601
- Email: ANEZZANG@yuhs.ac
Study Locations
-
-
-
Seoul, Korea, Republic of
- Recruiting
- Gangnam Severacne Hospital Yonsei University College of Medicine
-
Contact:
- Jiwon Lee
- Phone Number: 82-2-2019-4601
- Email: BELIEF705@yuhs.ac
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 20 - 70 years of age who are scheduled for robotic assisted laparoscopic prostatectomy at the Department of Urology, Gangnam Severance Hospital,
- ASA-PS (American Society of Anesthesiology Body Rating) I-IlI,
- Patients with a BMI of 35 kg/m2 or less
Exclusion Criteria:
- Patients with lung disease
- BMI >35kg/m2
- Patients for whom positive end-tidal pressure cannot be applied (large bullae, severe cardiac disease)
- patient refusal
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: conventional PEEP
Apply of PEEP 5
|
Maintain positive end expiratory pressure at 5 cmH2O throughout the surgery.
|
|
Active Comparator: optimized PEEP
Apply of optimized PEEP derived using EIT (airtom®)
|
Immediately after induction of anesthesia, the patient remains unapplied to PEEP.
After pneumoperitoneum + Trendelenburg posture, an appropriate PEEP value is derived using electrical impedance tomography (airtom®).
And then derived value ( = optimized PEEP value) is applied until the end of the operation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PaO2/FiO2
Time Frame: end of surgery (before extubation)
|
PaO2/FiO2 is the ratio of arterial oxygen partial pressure (PaO2) to oxygen fraction (FiO2), and is a commonly used indicator for evaluating pulmonary ventilation and diagnosing lung damage.
Using this index, it is possible to determine whether oxygen obtained through the lungs is well delivered to the blood or not.
It can be easily obtained by arterial blood gas analysis without complicated formulas or graphs.
|
end of surgery (before extubation)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PaO2/FiO2
Time Frame: 15 minutes after intubation, 1 hour after pnemoperitoneum
|
partial pressure (PaO2) to oxygen fraction (FiO2), and is a commonly used indicator for evaluating pulmonary ventilation and diagnosing lung damage.
Using this index, it is possible to determine whether oxygen obtained through the lungs is well delivered to the blood or not.
It can be easily obtained by arterial blood gas analysis without complicated formulas or graphs.
|
15 minutes after intubation, 1 hour after pnemoperitoneum
|
|
ROI (region of interests)
Time Frame: 15 minutes after intubation, 1 hour after pnemoperitoneum, end of surgery (before extubation)
|
region of interest using EIT
|
15 minutes after intubation, 1 hour after pnemoperitoneum, end of surgery (before extubation)
|
|
inhomogeneity index
Time Frame: 15 minutes after intubation, 1 hour after pnemoperitoneum, end of surgery (before extubation)
|
inhomogeneity index : this index calculated from tidal EIT images representing the difference in impedance between the end of inspiration and the end of expiration.
|
15 minutes after intubation, 1 hour after pnemoperitoneum, end of surgery (before extubation)
|
|
total amount of fluid administered during surgery
Time Frame: end or surgery
|
end or surgery
|
|
|
total dose of vasopressor administered during surgery
Time Frame: end of surgery
|
end of surgery
|
|
|
length of hospitalization after surgery
Time Frame: 1 month after surgery
|
1 month after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 3, 2023
Primary Completion (Estimated)
November 10, 2024
Study Completion (Estimated)
November 10, 2024
Study Registration Dates
First Submitted
December 9, 2022
First Submitted That Met QC Criteria
December 21, 2022
First Posted (Actual)
December 30, 2022
Study Record Updates
Last Update Posted (Actual)
April 8, 2024
Last Update Submitted That Met QC Criteria
April 5, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3-2022-0361
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostate Cancer
-
Cancer Institute and Hospital, Chinese Academy...RecruitingProstate Cancer Castration-resistant Prostate CancerChina
-
Roswell Park Cancer InstituteRecruitingObesity | Overweight | Cancer Survivor | Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage A Prostate Cancer | Stage... and other conditionsUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingProstate Cancer Castration-resistant Prostate CancerChina
-
Jonsson Comprehensive Cancer CenterProgenics Pharmaceuticals, Inc.TerminatedRandomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer (PSMA-dRT)Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Stage I Prostate...United States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate...United States
-
Barbara Ann Karmanos Cancer InstituteGenentech, Inc.CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Regeneron Pharmaceuticals; Prostate Cancer FoundationWithdrawnStage III Prostate Cancer | Stage IV Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage IIIA Prostate Cancer | Stage IIIB Prostate Cancer | Stage IIIC Prostate Cancer
-
University of Southern CaliforniaNational Cancer Institute (NCI); SanofiTerminatedDiarrhea | Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Ryan Kohlbrenner, MDRadiological Society of North AmericaCompletedProstate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Prostate Carcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage...United States
Clinical Trials on conventional PEEP
-
Konkuk University Medical CenterUnknownValvular Heart Disease
-
Seoul National University HospitalCompletedAtelectasis, Postoperative PulmonaryKorea, Republic of
-
Samsung Medical CenterCompletedUterine Myoma | Ovarian Cyst | Laparoscopic Gynecologic SurgeryKorea, Republic of
-
Bursa City HospitalNot yet recruitingCardiac Surgery | Mechanical Power | Postoperative Pulmonary Complications (PPCs)Turkey (Türkiye)
-
Gachon University Gil Medical CenterCompletedThe Effect of Positive End Expiratory Pressure (PEEP) During Laparoscopic Cholecystectomy (lapaPEEP)Brain IschemiaKorea, Republic of
-
Al-Azhar UniversityCompletedPulmonary Atelectasis, PostoperativeEgypt
-
Jiaxiang ChenEnrolling by invitation
-
Hongpeng LiCompletedTraumatic Brain Injury | Mechanical Ventilation Complication
-
Ankara City Hospital BilkentNot yet recruitingMechanical Ventilation | Postoperative Pulmonary Complications | Impaired Oxygenation
-
University Hospital, Basel, SwitzerlandRecruiting